20 Menstrual Irregularities
Abnormal Bleeding
To understand and diagnose the various causes of menstrual irregularities, the examiner must have a thorough knowledge of normal physiology (Fig. 20-1). Although the history is important, it is seldom diagnostic and serves only as a guide to the origin of the bleeding. In most patients, hormonal or cytologic studies are necessary to establish the correct diagnosis.
Anovulatory Bleeding
Estrogen-Withdrawal Bleeding
In estrogen-withdrawal bleeding, the endometrium proliferates and remains stable as long as the estrogen level remains above the threshold. When the estrogen falls below the threshold, bleeding occurs. In the absence of progesterone, the endometrium is not in the secretory phase, and bleeding is often prolonged and profuse. This type of bleeding often occurs during adolescence and the climacteric.
Dysfunctional Ovulatory Bleeding
Dysfunctional ovulatory bleeding may be suspected from the history and confirmed with simple investigations (Table 20-1). Ovulatory bleeding is usually associated with a regular cycle length, occasional ovulation pain (mittelschmerz), premenstrual symptoms (e.g., breast soreness, bloating, weight gain, mood changes), and a biphasic basal body temperature. Anovulatory bleeding causes an irregular cycle in which bleeding is not preceded by or associated with subjective symptoms. The basal body temperature pattern is monophasic.
CRITERIA | OVULATORY BLEEDING | ANOVULATORY BLEEDING |
---|---|---|
History | Regular cycle length Ovulation pain (mittelschmerz) Premenstrual molimina (breast soreness, bloating, weight gain, mood change) Dysmenorrhea (cramps up to 12 hr before flow and/or for first 2 days of flow) | Irregular cycles in which bleeding is not preceded by or associated with subjective symptoms |
Basal body temperature record | Biphasic pattern | Monophasic pattern |
Cervical mucus | Preovulatory: thin, clear, watery mucus with stretchability (spinnbarkeit) and ferning | Always dominated by estrogen |
Maturation index | Preovulatory: dominated by superficial cells Postovulatory: shift to high percentage of intermediate cells | Always a marked right shift due to high estrogen level |
Premenstrual endometrial biopsy | Secretory endometrium | Proliferative and possibly hyperplastic changes |
Serum progesterone level | Preovulatory: <1 ng/mL Postovulatory: >5 ng/mL | Never exceeds 5 ng/mL; usually preovulatory values |
From Strickler RC: Dysfunctional uterine bleeding: diagnosis and treatment. Postgrad Med 66:135-146, 1979.
Bleeding Patterns
Recognition of particular bleeding patterns is another way of considering cases of abnormal vaginal bleeding (Table 20-2). Menorrhagia, or hypermenorrhea (excessive menstrual bleeding, >60-80 mL), is often caused by local gynecologic disease (e.g., polyps, cancer, salpingitis, uterine fibroids). It also occurs in association with intrauterine contraceptive devices (IUDs).
TERM | BLEEDING PATTERN |
---|---|
Menorrhagia | Excessive flow (amount and/or duration) with normal cycle (21-35 days) |
Polymenorrhea | Normal flow with cycle shorter than 21 days |
Polymenorrhagia | Excessive flow with cycle shorter than 21 days |
Metrorrhagia | Excessive flow that is acyclic |
Metrostaxis | Continuous bleeding |
Ovulatory bleeding (pseudopolymenorrhea) | Spotting or light flow at time of midcycle estrogen nadir |
Premenstrual staining | Spotting or light flow up to 7 days before menstruation in ovulatory cycle |
From Strickler RC: Dysfunctional uterine bleeding: diagnosis and treatment. Postgrad Med 66:135-146, 1979.
Polymenorrhagia is excessive cyclic hemorrhage occurring at intervals of 21 days or less. This type of bleeding is most often the result of anovulatory cycles.
Nature of Patient
Before menarche, a characteristic sequence of events begins at about age 8 years (Fig. 20-2). Breast buds develop, pubic hairs appear, breasts enlarge, axillary hairs appear, and finally a height spurt occurs. Menstrual function usually begins after the height spurt. About 6 months before menarche, physiologic leukorrhea occurs. In the first year after menarche, 55% of menses are anovulatory, with a sharp decline to about 7% by 8 years after menarche. Usually, 15 months is required for completion of the first 10 menstrual cycles. This means that when menses begin, it is unusual for them to occur at regular monthly intervals.
Figure 20-2 Relationship of pubertal events in adolescent girls.
(From Lopez RI: Menstrual irregularities in teenage girls. Drug Ther April:49, 1981.)
The average age at which girls begin to menstruate is 12 years. Table 20-3 shows the characteristics of normal menstruation. Bleeding that occurs before 9 to 10 years of age is abnormal, and local pathology as well as adrenal and ovarian tumors must be suspected. Because some teenage girls are reluctant to volunteer information about their menstrual periods, it is essential that physicians routinely ask a series of questions, as follows:
CHARACTERISTICS | RANGE | AVERAGE |
---|---|---|
Menarche (age of onset) | 9-17 yr | 12.5 yr |
Cycle length (interval) | 21-35 days | 28 days |
Duration of flow | 1-8 days | 3-5 days |
Amount of flow | 10-80 mL | 35 mL |
Onset of menopause | 45-55 yr | 47-50 yr |
∗ Range and averages for American women.
From Hamilton C: Vaginal bleeding: evaluation and management. Res Staff Physician Nov:62-64, 1981.
In adolescence, amenorrhea, dysmenorrhea and abnormal uterine bleeding are common, affecting about 75% of adolescents. Both primary and secondary amenorrhea can occur. When pelvic anatomy and ovarian function are normal, dysmenorrhea is considered primarySecondary dysmenorrhea occurs when dysmenorrhea is associated with pelvic or hormonal pathology. In adolescents, anovulation causes virtually all instances of dysfunctional uterine bleeding and 90% of all instances of abnormal uterine bleeding.
During the reproductive years, dysfunctional uterine bleeding and bleeding from pregnancy complications, tumors, or fibroids may occur (Table 20-4). A menstruating woman of any age can bleed from complications of pregnancy. Anovulatory estrogen-withdrawal bleeding is the most common cause of irregular menses during the reproductive and perimenopausal years, accounting for 40% of menstrual disturbances in the perimenopausal years.
Menstruation and variations: |
Ovulatory spotting (midcycle) |
Pregnancy complications: |
Early (<20 wk): |
Implantation bleeding |
Abortion |
Ectopic pregnancy |
Trophoblastic disease |
Late (>20 wk): |
Placenta previa, vasa praevia, other |
Postpartum: |
Uterine atony |
Retained products |
Normal delivery |
Disorders of central nervous system—hypothalamic-ovarian-pituitary axis |
Dysfunctional uterine bleeding: |
Anovulatory (80%-90%) |
Ovulatory |
Functioning ovarian cysts or tumors |
Emotional stress |
Anticholinergic drugs |
Exogenous hormones: |
Estrogen |
Estrogen-progestin oral contraceptives |
Trauma |
Anticoagulant drugs |
Organic gynecologic disease: |
Pelvic infections |
Neoplastic diseases: |
Benign |
Malignant |
Adenomyosis |
Systemic disease |
Generalized bleeding disorders |
Thyroid disease |
From Hamilton C: Vaginal bleeding: evaluation and management. Res Staff Physician Nov:62-64, 1981
Other, less common causes of abnormal vaginal bleeding in perimenopausal women are organic lesions (neoplasm or inflammatory diseases of the cervix, vagina, and endometrium), constitutional diseases (hypothyroidism, hyperthyroidism, Cushing’s disease, cirrhosis, thrombocytopenia), and certain drugs (Table 20-5). In postmenopausal women, bleeding may result from endometrial and cervical cancers.
GROUP AND GENERIC NAMES | TRADE AND COMMON NAMES |
---|---|
Amphetamines | Desoxyn, Obetrol∗ |
Anticoagulants | Coumadin, heparin |
Benzodiazepines: | |
Diazepam, oxazepam | Valium, Serax∗ |
Benzamide derivatives: | |
Procainamide, procarbazine | Pronestyl, Matulane |
Butyrophenones | Haldol, Inapsine∗ |
Cannabis | Marijuana |
Chlordiazepoxide | Librium |
Cimetidine | Tagamet |
Ethyl alcohol | Whiskey, wine, beer |
Isoniazid | Isonicotinic acid hydrazide∗ |
Methyldopa | Aldomet∗ |
Monoamine oxidase inhibitors | Eutonyl, Nardil |
Opiates∗ | Morphine, heroin, methadone∗ |
Phenothiazines∗ | Compazine, Thorazine, Phenergan∗ |
Prostaglandin inhibitors | Motrin, Indocin |
Rauwolfia | Raudixin |
Reserpine∗ | Serpasil∗ |
Spironolactone∗ | Aldactone∗ |
Steroids | |
Estrogens∗ | Premarin, oral contraceptives∗ |
Progesterones∗ | Provera, oral contraceptives∗ |
Testosterone∗ | Android∗ |
Thyroid hormones | Synthroid, Cytomel |
Thioxanthenes∗ | Navane∗ |
Tricyclic antidepressants∗ | Elavil∗ |
∗ May also produce galactorrhea.
Modified from Murata JN: Abnormal genital bleeding and secondary amenorrhea: common gynecological problems. J Obstet Gynecol Neonatal Nurs 19:26-36, 1990.